REFERENCES
- National Institute on Drug Abuse. Available at: http://www.nida.nih.gov/about/welcome/MessageBathSalts211.html. Last accessed on March 25, 2011.
- The Washington Post. Available at: http://www.washingtonpost.com/national/officials-fear-bath-salts-becoming-the-next-big-drug-menace/2011/01/22/ABybyRJ_story.html. Last accessed on March 25, 2011.
- United States Drug Enforcement Administration. Available at: http://www.deadiversion.usdoj.gov/drugs_concern/mephedrone.pdf. Last accessed on March 13, 2011.
- Brandt SD, Freeman S, Sumnall HR, Measham F, Cole J. Analysis of NRG ‘legal highs’ in the UK: identification and formation of novel cathinones. Drug Test Anal 2011; 3(9):569–75.
- Gibbons S, Zloh M. An analysis of the ‘legal high’ mephedrone. Bioorg Med Chem Lett 2010; 20(14):4135–4139.
- Europol-EMCDDA joint report on a new psychoactive substance: 4-methylmethcathinone (mephedrone). April 2010. Available at http://www.emcdda.europa.eu/html.cfm/index116639EN.html. Last accessed on March 20, 2011.
- McElrath K, O’Neill C. Experiences with mephedrone pre- and post-legislative controls: Perceptions of safety and sources of supply. Int J Drug Policy 2011; 22(2):120–7.
- Vardakou I, Pistos C, Spiliopoulou C. Drugs for youth via Internet and the example of mephedrone. Toxicol Lett 2011; 201(3):191–195.
- Schifano F, Albanese A, Fergus S, Stair JL, Deluca P, Corazza O, Davey Z, Corkery J, Siemann H, Scherbaum N, Farre M, Torrens M, Demetrovics Z, Ghodse AH. Psychonaut Web Mapping; ReDNet Research Groups. Mephedrone (4-methylmethcathinone; ‘meow meow’): Chemical, pharmacological, and clinical issues. Psychopharmacology (Berl) 2011; 214(3):593–602 [Epub 2010 Nov 12].
- Winstock AR, Mitcheson LR, Deluca P, Davey Z, Corazza O, Schifano F. Mephedrone, new kid for the chop? Addiction 2010; 106:154–161.
- Wood DM, Davies S, Greene SL, Button J, Holt DW, Ramsey J, Dargan PI. Case series of individuals with analytically confirmed acute mephedrone toxicity. Clin Toxicol (Phila) 2010; 48(9):924–927.
- Wood DM, Davies S, Puchnarewicz M, Button J, Archer R, Ovaska H, Ramsey J, Lee T, Holt DW, Dargan PI. Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol 2010; 6(3):327–330.
- Wood DM, Greene SL, Dargan PI. Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone. Emerg Med J 2011; 28(4):280–2.
- Garrett G, Sweeney M. The serotonin syndrome as a result of mephedrone toxicity. BMJ Case Rep 2010. doi:10.1136/bcr.04.2010.2925.
- Sammler EM, Foley PL, Lauder GD, Wilson SJ, Goudie AR, O’Riordan JI. A harmless high? Lancet 2010; 376:742.
- Nicholson PJ, Quinn MJ, Dodd JD. Headshop heartache: Acute mephedrone ‘meow’ myocarditis. Heart 2010; 96:2051–2052.
- Lusthof KJ, Oosting R, Maes A, Verschraagen M, Dijkhuizen A, Sprong AG. A case of extreme agitation and death after the use of mephedrone in the Netherlands. Forensic Sci Int 2011; 206(1–3):e93–e95 [Epub January 11, 2011].
- NMS Labs. Available at http://www.nmslab.com/tests/Mephedrone—MDPV-Stimulants-Designer-Drug-Test–Blood/2623B. Last accessed on August 10, 2011.
- Meyer M, Wilhelm J, Peters F, Maurer H. Beta-keto amphetamines: Studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. Anal Bioanal Chem 2010; 397:1225–1233.
- Chemistry Information Sheet. UniCel® DxC800 System Homogenous Enzyme Immunoassay Method. Fullerton, CA: Beckman Coulter, Inc. 2010.